Boehringer bags PVT’s viral vector platform for cancer vaccine R&D

Salmonella-based delivery system enables oncolytic parvovirus to shrink solid tumors and generate antitumor immune memory

Researchers have engineered a Salmonella vector that delivers the H-1 parvovirus directly into solid tumors, overcoming the key limitation o

Phase I trial shows needle-free pan-Sarbecovirus vaccine is safe with modest immune responses

This article reports on a first-in-human Phase I clinical trial of pEVAC-PS, a computationally designed pan-Sarbecovirus vaccine delivered v

Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing

Nieuwe regels in juni: neutrale verpakkingen voor meer tabaksproducten, HPV-vaccin goedkoper, ecocheques voor fairtrade

Vanaf 1 juni 2025 worden de regels voor neutrale verpakkingen van tabaksproducten uitgebreid naar sigaren, cigarillo's, pijptabak, rookappar

Personalized mRNA Cancer Vaccine Shows 49% Risk Reduction at 5-Year Follow-up

Moderna and Merck report promising 5-year follow-up results for their personalized mRNA cancer vaccine combined with Keytruda immunotherapy.

Phages redirect vaccine immunity to attack cancer cells in mouse study

Researchers have demonstrated a novel approach to cancer treatment by using bacteriophages (viruses that infect bacteria) to redirect vaccin